I am a Pharmacy graduate from the National University of Singapore (NUS) with a research interest in organic synthesis, toxicology, and infectious diseases. In October 2020, I embarked on my doctoral studies in Chemistry as part of the University of Cambridge’s Syntech CDT.
I have been affiliated with the Agency for Science, Technology, and Research (A*STAR) since 2011, and have worked in the following Research Institutes (RIs):
- Experimental Drug Development Centre (EDDC) (2019 – 2020)
- Bioinformatics Institute (BII) (2017)
- Institute of Bioengineering and Nanotechnology (now IBB) (2015)
- Institute of Materials Research and Engineering (IMRE) (2011 – 2012)
In NUS, my undergraduate research work consisted of two research projects that revolved around tuberculosis: 1) discovering antitubercular agents that utilise new mechanisms of action against Mycobacterium tuberculosis, and 2) finding ways to reduce side effects of the tuberculosis drug regimens in use.
Engineered Enzymes that Retain and Regenerate their Cofactors Enable Continuous-Flow Biocatalysis
Aqueous synthesis of a small-molecule lanthanide chelator amenable to copper-free click chemistry
Applications of Machine Learning in Decision Analysis for Dose Management for Dofetilide
AND
Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non-Small Cell Lung Cancer
Tracking the popularity and outcomes of all bioRxiv preprints
Development and validation of serological markers for detecting recent exposure to Plasmodium vivax infection
AND
Antimalarial drug mefloquine kills both trophozoite and cyst stages of Entamoeba
Robust Antibacterial Activity of Tungsten Oxide (WO3-X) Nanodots
A pharmacokinetic-pharmacodynamic assessment of the hepatic and bone-marrow toxicities of the new trypanoside fexinidazole
Drug prescription pattern in European neonatal units
A direct selection strategy for isolating aptamers with pH-sensitive binding activity
Incorporation of doxorubicin in different polymer nanoparticles and their anti-cancer activity
Atropselective Oxidation of 2,2',3,3',4,6'-Hexachlorobiphenyl (PCB 132) to Hydroxylated Metabolites by Human Liver Microsomes: Involvement of Arene Oxide Intermediates
1 month
Zhang-He Goh
Thank you for pointing this out! I have now edited the Figure accordingly.